All In MedTech

FDA Clearance Tracker · P050044-S012

VITAGEL SURGICAL HEMOSTAT

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 23, 2010 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 23, 2010

Approved

Time to decision

200 days

Received Jan 4, 2010. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P050044-S012
Device name
VITAGEL SURGICAL HEMOSTAT
Applicant
Stryker Corp.
Applicant location
Kalamazoo, MI
Received
Jan 4, 2010
Decided
Jul 23, 2010
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P050044

Device type

Device class
Class III
Regulation
21 CFR 878.4490

Every decision under product code LMF

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A MANUFACTURING SITE LOCATED AT ORTHOVITA, INC. IN MALVERN, PENNSYLVANIA.

Source documents

Other decisions for Stryker Corp.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

3 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.